COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Merger closed, proposed name announced, AGM in 21 days...

<< Previous

Bullboard Posts

Next >>

Comment by Tencentson Jun 25, 2024 1:37pm

111 Views

Post# 36105378

RE:Merger closed, proposed name announced, AGM in 21 days...

I would expect the following to happen at the agm
1. approval of name
2. approval of merger
3.appointment of auditors
4. approval of board
5.approval of financial statements 2023

operational business matters are unlikely to be considered
these are for the executive management team to deal with

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks